Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Formula Systems (1985) Ltd., a global IT holding company traded on Nasdaq and TASE under ticker FORTY, announced a significant increase in revenue, operating income, and net income for Q2 and the first half of 2026, with record-breaking financial performance compared to prior periods. The company also declared a dividend reflecting its strong cash …
Edible Garden AG Incorporated announced the hiring of Ernesto Insignares, an experienced Tetra Pak executive, as Senior Project Manager to lead the completion and commissioning of its Prairie Hills facility in Iowa. This site will serve as a major manufacturing hub for ready-to-drink nutritional beverages, enhancing the company’s Farm-to-Formula st…
Citi strategists judge that remarks by Federal Reserve Chair Kevin Warsh at the Jackson Hole symposium are unlikely to reverse the recent dollar sell-off. They say the primary vulnerabilities to a continued dollar slide stem from valuation, market positioning and geopolitical risks rather than a substantive probability of a hawkish shock from Warsh…
Quantum Cyber N.V., a Nasdaq-listed autonomous defense technology company, announced the appointment of Dennis Schnur as Head of U.S. Sales to support its commercial expansion in the U.S. following acquisition of a Connecticut manufacturing facility and the assembly of its first mini-interceptor drone. Schnur's extensive distribution experience is …
PMGC Holdings Inc. announced a non-binding term sheet with space technology company Orbit2Orbit to conduct a microgravity research study of its biopharmaceutical assets EL-22 and EL-32 targeting muscle loss during spaceflight. The collaboration will leverage Orbit2Orbit's Mice2Space platform and PMGC's manufacturing subsidiary A&B Aerospace to supp…
Swvl Holdings Corp announced a $13 million strategic investment round through a private placement led by Coefficient LP, backed by the Sawiris family. The funds will support Swvl's U.S. market expansion, new lending offerings for transport partners, and strengthen its balance sheet as it approaches operating breakeven with strong revenue growth in …
Zevra Therapeutics announced the presentation of long-term real-world data on its approved drug MIPLYFFA® (arimoclomol) for treating Niemann-Pick Disease Type C (NPC). The data underscore sustained disease stabilization across diverse patient populations up to 8 years, with favorable safety profile and no treatment-related discontinuations. These f…
FuelCell Energy, Inc. announced that it will release its third quarter 2026 financial results before the market opens on September 2, 2026. The company's management will host a conference call at 10:00 a.m. Eastern Time on the same day to discuss the results and provide a business update. The call will be webcast live and available for replay on th…
Nova Minerals Corp hosted a U.S. Congressional delegation at its Estelle Gold and Critical Minerals Project in Alaska, emphasizing the project's significance as one of the world's largest undeveloped gold deposits and a key component in securing a domestic antimony supply chain. The visit underscores growing federal interest, supported by a $43.4 m…
Melrose Industries (MLSPF) is showing the technical base and extreme short-side positioning that can produce outsized rebounds. Enter at $6.58 with a tight stop and staged targets. This is a high-risk, high-reward swing trade: favorable reward-to-risk driven by potential rapid short-covering, balanced against OTC liquidity and fundamental opacity.
KANZHUN LIMITED, a leading Chinese online recruitment platform traded on Nasdaq and Hong Kong exchanges, declared an annual cash dividend of US$0.255 per ordinary share (US$0.510 per ADS), totaling approximately US$230 million. This dividend, supported by surplus cash and combined with over US$300 million in share buybacks this year, signifies the …
Dick’s Sporting Goods shares dropped sharply in pre-market trading after the retailer reported fiscal second-quarter 2026 results, with adjusted earnings per share coming in about 15% below analyst expectations. Revenue slightly topped consensus at roughly $5.64 billion, but the company said integration expenses related to its September 2025 acquis…
United Airlines expects to receive a sufficient number of Airbus A321XLR aircraft to underpin a planned European expansion in 2027, the carrier said, even as Airbus production and supply-chain issues have created delivery challenges industrywide. The long-range single-aisle jet will be used on five new European routes next year and form part of the…
KANZHUN LIMITED, a leading online recruitment platform in China, announced its Q2 2026 financial results showing a 14.1% revenue increase and 173.1% surge in net income year-over-year. Key operational metrics like paid enterprise customers and average monthly active users also grew significantly. The company enhanced its AI capabilities to improve …
OrthoPediatrics Corp. has announced the full commercial launch of its 3P Pediatric Plating Platform Hip System following over 350 successful implantations during a limited launch phase. The system provides advanced plating solutions for pediatric orthopedic trauma and deformity corrections and is the first in a series of planned products to moderni…
Ocugen, Inc., a US-based biotechnology company specializing in gene therapies for blindness diseases, announced it will present its modifier gene therapy platform and clinical trial results at several investor and industry conferences in September 2026. The presentations aim to showcase the safety and efficacy of its OCU410 gene therapy for geograp…
Sun Communities, Inc., a REIT specializing in manufactured housing and RV communities, announced the appointment of Robert A. Garechana as Executive Vice President and Chief Financial Officer effective September 8, 2026. Garechana brings over 20 years of REIT finance experience, previously serving in top financial roles at Equity Residential. The c…
BioCryst Pharmaceuticals announced that Japan's Ministry of Health, Labor and Welfare has approved ORLADEYO (berotralstat) for prophylactic treatment of hereditary angioedema (HAE) in pediatric patients aged 2 to under 12 years. This is the first and only oral prophylactic therapy approved for this age group in Japan. The approval is based on posit…
Parabilis Medicines announced the appointment of Dr. Craig L. Tendler, an accomplished oncology drug development leader formerly at Johnson & Johnson, to its Board of Directors. Dr. Tendler's extensive experience in clinical development, medical affairs, and successful oncology drug approvals will support Parabilis's ongoing clinical programs, incl…
Beyond Air, Inc. has entered into an agreement to sell its 58% stake in NeuroNOS Israel Ltd., a biopharmaceutical company focused on neurological disorders, to UNIVO Pharmaceutical Industries Ltd. In exchange, Beyond Air will receive 19.99% ownership in UNIVO, warrants, and milestone payments up to $32.5 million tied to NeuroNOS's development and c…
Aveanna Healthcare Holdings Inc., a leading provider of pediatric and adult healthcare services in the U.S., announced that its management team will present at the 2026 Jefferies Healthcare Services and Technology Conference in Nashville. The event will include a presentation and investor meetings, with a webcast available for interested parties.
Sagimet Biosciences announced that its AURORA Phase 3 clinical trial for denifanstat, a novel oral FASN inhibitor for moderate to severe acne, is on track to begin patient enrollment in Q4 2026. The trial plans to enroll approximately 800 U.S. patients, including 450 adolescents, to evaluate both efficacy and long-term safety. Positive prior result…
Gain Therapeutics, a clinical-stage biotech company specializing in allosteric small molecule therapies, announced that CEO Gene Mack will participate in one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14-16, 2026. The company’s on-demand presentation will be available starting Sep…
Immatics N.V., a clinical-stage biopharmaceutical company focused on precision targeting of PRAME in cancer therapies, announced a $150 million underwritten offering of ordinary shares and pre-funded warrants. The proceeds will support its clinical programs involving TCR T-cell therapies and bispecifics. The offering is expected to close by August …
Lumexa Imaging Holdings, a leading provider of outpatient imaging services, announced CEO Caitlin Zulla and CFO Tony Martin will participate in several upcoming investor conferences, including Wells Fargo Healthcare Conference, JP Morgan High Yield Conference, Jefferies Healthcare Conference, and Deutsche Bank Healthcare Summit. The company highlig…
